NCT04545047View on ClinicalTrials.gov

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

CompletedOBSERVATIONAL
Enrollment

5,044

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Coronavirus Disease 2019 (COVID-19)
Interventions
BIOLOGICAL

COVID-19 convalescent plasma

Convalescent plasma collected from individuals who have recovered from COVID-19

Trial Locations (2)

98108

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

02130

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

VA Office of Research and Development

FED

NCT04545047 - Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19 | Biotech Hunter | Biotech Hunter